Nephrectomy

Entity type image
Type: Keyphrase
Name: Nephrectomy
First reported May 15 2013 - Updated May 15 2013 - 1 reports

18-month-old baby battles cancer of the kidney

May 15, 2013 by SAMUEL AWOYINFA Leave a CommentOluwafeyikemi (before) and Now| credits: File copySAMUEL AWOYINFA writes on the predicament of a child battling tumour, with doctors saying she needs N1.5m to treat itThis is not the best of times for Mr. ... [Published Nigeria Punch - May 15 2013]
First reported May 13 2013 - Updated May 13 2013 - 1 reports

Metabolic syndrome a risk factor for radical nephrectomy complications

The presence of metabolic syndrome increases the risk of complications associated with radical nephrectomy, according to an analysis of the American College of Surgeons National Surgical Quality Improvement Program.The retrospective review, presented ... [Published Trends In Urology & Men's health - May 13 2013]
First reported May 08 2013 - Updated May 09 2013 - 2 reports

Study finds disparity in live-donor kidney transplants in African Americans

While the percentage of kidney transplants involving live donors has remained stable for other minority populations, African Americans have seen a decline in live donors even as more of them receive kidney transplants, according to a study by Henry Ford ... [Published News-Medical.Net - May 09 2013]
First reported May 08 2013 - Updated May 08 2013 - 1 reports

At Increased Cost, Robotic Partial Nephrectomy Improves Kidney Cancer Outcomes

The use of robotic partial nephrectomy to remove kidney cancer tumors has increased in recent years, becoming more commonly used than open or laparoscopic partial nephrectomy and resulting in better outcomes. However, data from a study presented at the ... [Published Cancernetwork.com - May 08 2013]
First reported May 07 2013 - Updated May 07 2013 - 1 reports

Prognosis of Dialysed Patients after Kidney Transplant Failure

a1st Department of Internal Medicine, Division of Nephrology, Faculty of Medicine, Medical & Health Science Centre, University of Debrecen, 4012, Debrecen, Nagyerdei krt. 98., Hungary;bFresenius Medical Care, Centre of Nephrology, 3526, Miskolc, Szentpéteri ... [Published Sexual Development - May 07 2013]
First reported May 07 2013 - Updated May 07 2013 - 1 reports

AUA 2013 - Session Highlights: Surveillance of renal function after (partial) tumor nephrectomy by cystatin C-measurement

SAN DIEGO, CA USA (UroToday.com) - Limitations of serum creatinine (SCr) to estimate GFR, especially in the blind range of 60-90 ml/min/1.73m2, are well established. This may significantly impact surgeon’s ability to monitor renal function and the ability ... [Published UroToday - May 07 2013]
First reported May 05 2013 - Updated May 05 2013 - 1 reports

Pomegranate juice: A cure for prostate cancer?

Erik P. Castle, M.D.Dr. Erik Castle is a board-certified urologist who joined the Mayo Clinic staff in Arizona in 2007.Dr. Castle is an associate professor of urology at College of Medicine, Mayo Clinic, and a senior associate consultant in the Department ... [Published MayoClinic.com - May 05 2013]
First reported May 04 2013 - Updated May 04 2013 - 1 reports

Disease-Specific Survival in De Novo Metastatic Renal Cell Carcinoma in the Cytokine and Targeted Therapy Era

by Sumanta K. Pal, Rebecca A. Nelson, Nicholas VogelzangBackgroundRecent phase III studies of targeted agents for metastatic renal cell carcinoma (mRCC) have generated median survival estimates that far exceed those observed during the cytokine era. However, ... [Published Elites TV - May 04 2013]
First reported Apr 22 2013 - Updated Apr 22 2013 - 1 reports

Renal Cell Carcinoma – Multimodal management for advanced disease

Renal Cell Carcinoma - Multimodal management for advanced diseaseRenal cell carcinoma (RCC) accounts for only about 3% of all cancer incidences. However, worldwide incidence is increasing by about 2% to 3% per year, and in the United States, 39,000 new ... [Published Medical Grapevine - Apr 22 2013]
First reported Apr 19 2013 - Updated Apr 19 2013 - 1 reports

Development of accurate models for individualized prediction of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma - Abstract

BACKGROUND: There is limited evidence to guide patient selection for cytoreductive nephrectomy (CN) following the diagnosis of metastatic renal cell carcinoma (mRCC).OBJECTIVE: Given the significant variability in oncologic outcomes following surgery, ... [Published UroToday - Apr 19 2013]
First reported Apr 18 2013 - Updated Apr 18 2013 - 1 reports

Renal Cancer: Surgery May Compromise Outcome for Some Older Patients; Surveillance May Prolong Survival

Approximately two-thirds of kidney cancer tumors diagnosed in the United States are asymptomatic and small. Surgery remains the standard of care even though many of these tumors are likely to be indolent or even benign. Now, investigators have reported ... [Published Oncology Times - Apr 18 2013]
First reported Apr 06 2013 - Updated Apr 06 2013 - 1 reports

Kidney sparing surgery underutilized for patients who need it most

The study found that partial and complete kidney removal (total nephrectomy) and energy-based techniques to destroy tumors are all on the rise. Surprisingly, the patients most in need of kidney-sparing surgery are still more likely to undergo total nephrectomy. ... [Published News from Kidney Cancer Association - Apr 06 2013]
Entities: Kidney, Nephrectomy, Tumor

Quotes

...the kidney transplant process," says Jesse D Sammon, D O , a researcher at Henry Ford's Vattikuti Urology Institute and lead author of the study. "This is particularly striking in the use of transplant kidneys from living donors."
...and Medical Director of Perioperative Services at Maimonides Medical Center in Brooklyn, N Y and co- principal investigator on this research. "We are excited by the results, which support our Medical Center's goal of an opioid-sparing postoperative patient experience to avoid the often adverse side effects associated with the use of opioids."
"But African Americans averaged only 18.6 percent LDN to KT ratio, and that fell over the study period" Dr. Sammon says
"Donor nephrectomy using the Robot was not the standard of care in the years 2008, 2009 and 2010," according to the complaint. "[Dr. Kortz], however, told surgical Patients D P , Patient E W, Patient R M , Patient C C , Patient M C , and Patient S L that the Robot was the "gold standard" for donor nephrectomy."

More Content

All (39) | News (35) | Reports (1) | Blogs (3) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Immunicum AB: Promising data for cancer vaccine... [Published FinanzNachrichten.de - May 20 2013]
18-month-old baby battles cancer of the kidney [Published Nigeria Punch - May 15 2013]
Metabolic syndrome a risk factor for radical ne... [Published Trends In Urology & Men's health - May 13 2013]
Dr. Allen’s Device Dissolves Kidney Stones at H... [Published PRWeb - May 10 2013]
Study finds disparity in live-donor kidney tran... [Published News-Medical.Net - May 09 2013]
Pacira Pharmaceuticals Releases Exparel Studies [Published Individual.com - May 09 2013]
Pacira Pharmaceuticals' CEO Discusses Q1 2013 R... [Published Seeking Alpha - May 08 2013]
More African-Americans have kidney transplants,... [Published EurekAlert! - May 08 2013]
At Increased Cost, Robotic Partial Nephrectomy ... [Published Cancernetwork.com - May 08 2013]
Prognosis of Dialysed Patients after Kidney Tra... [Published Sexual Development - May 07 2013]
AUA 2013 - Session Highlights: Surveillance of ... [Published UroToday - May 07 2013]
Two New Studies Support Use of EXPAREL via Infi... [Published Benzinga.com - May 06 2013]
Pomegranate juice: A cure for prostate cancer? [Published MayoClinic.com - May 05 2013]
Disease-Specific Survival in De Novo Metastatic... [Published Elites TV - May 04 2013]
Protein Expression of ZEB2 in Renal Cell Carcin... [Published Elites TV - May 03 2013]
ODAC to Review AVEO Oncology’s Investigational ... [Published Oncology Business Review - Apr 29 2013]
Dipeptidyl peptidase IV inhibitor attenuates ki... [Published 7thSpace - Apr 27 2013]
Collapsing glomerulopathy: a lesion under-recog... [Published JPMA - Apr 26 2013]
Erythrocyte sedimentation rate and anaemia are ... [Published UroToday - Apr 24 2013]
Renal Cell Carcinoma – Multimodal management fo... [Published Medical Grapevine - Apr 22 2013]
Trends in surgery for upper urinary tract calcu... [Published UroToday - Apr 19 2013]
Development of accurate models for individualiz... [Published UroToday - Apr 19 2013]
Renal Cancer: Surgery May Compromise Outcome fo... [Published Oncology Times - Apr 18 2013]
Axitinib eyed as first-line therapy for mRCC [Published Oncology Report - Apr 16 2013]
Boston Lab Bioengineered Functional Kidneys [Published Inquisitr - Apr 16 2013]
Colorado doc accused of misconduct with da Vinc... [Published MassDevice - Apr 15 2013]
Kesava Reddy Mannur : Consultant Obesity Surgeo... [Published Private Healthcare UK - Apr 14 2013]
Kidney sparing surgery underutilized for patien... [Published News from Kidney Cancer Association - Apr 06 2013]
The Veterinary Bioscience Institute Offers Micr... [Published PRWeb - Mar 14 2013]
Does Timing of Cytoreductive Nephrectomy Impact... [Published News from Kidney Cancer Association - Feb 19 2013]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Kidney sparing surgery underutilized for patien... [Published News from Kidney Cancer Association - Apr 06 2013]
The study found that partial and complete kidney removal (total nephrectomy) and energy-based techniques to destroy tumors are all on the rise. Surprisingly, the patients most in need of kidney-sparing surgery are still more likely to undergo total nephrectomy. ...
Does Timing of Cytoreductive Nephrectomy Impact... [Published News from Kidney Cancer Association - Feb 19 2013]
OBJECTIVE: To compare outcomes of metastatic renal cell carcinoma (mRCC) patients who underwent primary cytoreductive nephrectomy (CRN), followed by adjuvant sunitinib therapy, vs those who underwent primary sunitinib therapy before planned CRN. 02/19/2013 ...
Argos Therapeutics Enrolls Initial Patients in ... [Published News from Kidney Cancer Association - Jan 23 2013]
  Argos Therapeutics Enrolls Initial Patients in  Pivotal Phase 3 ADAPT Study AGS-003, first fully personalized, dendritic-based immunotherapy  being evaluated in combination with targeted therapy for mRCC Visit ADAPTkidneycancer.com ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.